Interventions for age-related diseases: Shifting the paradigm

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt


  • Inês Figueira
  • Adelaide Fernandes
  • Aleksandra Mladenovic Djordjevic
  • Lopez-Contreras, Andres
  • Catarina M Henriques
  • Colin Selman
  • Elisabete Ferreiro
  • Efstathios S Gonos
  • José Luis Trejo
  • Juhi Misra
  • Rasmussen, Lene Juel
  • Sara Xapelli
  • Timothy Ellam
  • Ilaria Bellantuono

Over 60% of people aged over 65 are affected by multiple morbidities, which are more difficult to treat, generate increased healthcare costs and lead to poor quality of life compared to individual diseases. With the number of older people steadily increasing this presents a societal challenge. Age is the major risk factor for age-related diseases and recent research developments have led to the proposal that pharmacological interventions targeting common mechanisms of ageing may be able to delay the onset of multimorbidity. Here we review the state of the knowledge of multimorbidity, appraise the available evidence supporting the role of mechanisms of ageing in the development of the most common age-related diseases and assess potential molecules that may successfully target those key mechanisms.

TidsskriftMechanisms of Ageing and Development
Sider (fra-til)69-92
Antal sider24
StatusUdgivet - dec. 2016

Antal downloads er baseret på statistik fra Google Scholar og

Ingen data tilgængelig

ID: 172129563